Literature DB >> 22136922

Consternation and confusion following EU patent judgment.

Ian Wilmut.   

Abstract

Mesh：

Year:  2011        PMID： 22136922     DOI： 10.1016/j.stem.2011.11.002

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  3 in total

1.  CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.

Authors:  Anna French; Kim Bure; David A Brindley
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

2.  Defining "research" in the US and EU: contrast of Sherley v. Sebelius and Brüstle v. Greenpeace rulings.

Authors:  Maude L Cuchiara; James Lawford Davies; Kirstin R W Matthews
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

3.  The impact of European embryonic stem cell patent decisions on research strategies.

Authors:  Aurélie Mahalatchimy; Emmanuelle Rial-Sebbag; Anne-Marie Duguet; Florence Taboulet; Anne Cambon-Thomsen
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.